ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $126,000 | -6.0% | 11,002 | +0.6% | 0.00% | – |
| Q3 2017 | $134,000 | +3.1% | 10,936 | -3.6% | 0.00% | – |
| Q2 2017 | $130,000 | -65.6% | 11,342 | -37.6% | 0.00% | -100.0% |
| Q1 2017 | $378,000 | +6.2% | 18,189 | +6.3% | 0.00% | 0.0% |
| Q4 2016 | $356,000 | -36.4% | 17,113 | +0.1% | 0.00% | -50.0% |
| Q3 2016 | $560,000 | +54.3% | 17,088 | +17.7% | 0.00% | +100.0% |
| Q2 2016 | $363,000 | +28.3% | 14,520 | +25.6% | 0.00% | 0.0% |
| Q1 2016 | $283,000 | -27.4% | 11,564 | -2.0% | 0.00% | 0.0% |
| Q4 2015 | $390,000 | +4.3% | 11,801 | +3.5% | 0.00% | -50.0% |
| Q3 2015 | $374,000 | – | 11,403 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |